Background illustration for clinical trials search

Chronic Lymphocytic Leukemia Clinical Trials

Browse 1,522 chronic lymphocytic leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies

for
Solid Malignancies
Location: Fairfax VA, Dallas TX, San Antonio TX
Sponsor: Carrick Therapeutics Limited

Sex: All

Age: 18+

Code: NCT06600789

Phase 1, Phase 2, Recruiting

Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease

for
Leukemia, Hairy Cell Leukemia, HCL
Location: Bethesda MD
Sponsor: Cambridge Antibody Technology

Sex: All

Age: 18+

Code: NCT00462189

Phase 1, Recruiting

Arizona Cancer Center Biospecimen Repository

for
Cancer
Location: Tucson AZ
Sponsor: University of Arizona

Sex: All

Age: 18+

Code: NCT00896935

Recruiting

Autologous CAR-T Cells Targeting B7-H3 in PDAC

for
Pancreas Cancer, Relapse, Resistant Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06158139

Phase 1, Recruiting

Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis

for
Solid Tumors, Hematological Malignancies
Location: Providence RI, East Greenwich RI
Sponsor: Rhode Island Hospital

Sex: All

Age: 18+

Code: NCT02213822

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies

for
Cancer, Tumor, Solid, Refractory Cancer
Location: Los Angeles CA
Sponsor: Taiga Biotechnologies, Inc.

Sex: All

Age: 18+

Code: NCT04640246

Phase 1, Phase 2, Recruiting

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

for
Chronic Myeloproliferative Disorders, Kidney Cancer, Leukemia,
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 2 - 18

Code: NCT00036712

Phase 2, Recruiting

DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

for
Hematologic Malignancies, Lymphoma, Multiple Myeloma, Leukemia,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 60+

Code: NCT06296368

Recruiting

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

for
Breast Cancer, Relapse, Resistant Cancer,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06347068

Phase 1, Recruiting

Radiation Therapy in Treating Patients Who Are Undergoing Surgery to Remove a Metastatic Brain Tumor

for
Metastatic Cancer
Location: Cleveland OH
Sponsor: The Cleveland Clinic

Sex: All

Age: 18+

Code: NCT00107367

Phase 1, Phase 2, Recruiting

A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer

for
Cancer
Location: Philadelphia PA
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Sex: All

Age: 0 - 18

Code: NCT00491946

Recruiting

A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant

for
Obesity, Malignant Neoplasm
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 13 - 30

Code: NCT04453072

Recruiting

Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

for
Unspecified Adult Solid Tumor, Protocol Specific
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT00992303

Recruiting

RIVER At Home Ketamine Protocols

for
Chronic Condition, Chronic Pain, Chronic Disease,
Location: Helena MT, Bigfork MT
Sponsor: RIVER Foundation

Sex: All

Age: 18+

Code: NCT06070766

Recruiting

Effectiveness of Central Oncology Navigation and the Use of an ORN

for
Cancer, Malignant Tumor
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06618274

Recruiting

Promoting Physical Activity In After-School Programs for Urban Adolescents

for
Unspecified Adult Solid Tumor, Protocol Specific
Location: Montclair NJ
Sponsor: Montclair State University

Sex: All

Age: 11 - 14

Code: NCT00301158

Recruiting

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

for
Tumor, Solid, Pancreatic Cancer, Melanoma
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT03454035

Phase 1, Recruiting

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors
Location: New York NY, Fairfax VA, Toronto, Orlando FL,
Sponsor: Avistone Biotechnology Co., Ltd.

Sex: All

Age: 18+

Code: NCT06307795

Phase 1, Recruiting

Young Adult Infusion Space Experience Satisfaction Survey

for
Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18 - 39

Code: NCT05720546

Recruiting

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

for
Head and Neck Cancer, Relapse, Recurrent, Refractory Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06096038

Phase 1, Recruiting

What is chronic lymphocytic leukemia?

Chronic lymphocytic leukemia, or CLL, is a slow growing cancer of B lymphocytes that build up in the blood, bone marrow, and lymph nodes. Most people are diagnosed around age 70, often with no symptoms; when symptoms come, they include tiredness, swollen lymph nodes, frequent infections, night sweats, and weight loss. Small lymphocytic lymphoma is the same disease when the cells sit mainly in lymph nodes, so it is studied in the same trials.

When treatment is needed, it is now mostly targeted pills: BTK inhibitors taken continuously, or venetoclax based combinations taken for a fixed time. CAR T cell therapy was approved for CLL in 2024 for people whose disease has stopped responding to both. Genetic features such as TP53 mutation, deletion 17p, and IGHV status strongly predict how CLL behaves and which trials fit. Other leukemias are on our leukemia clinical trials page.

Types of CLL clinical trials

Who can participate in CLL clinical trials?

How CLL is staged, and why it matters for trials

How to enroll in a CLL clinical trial